Packard CEO managed successful Prediction Company from startup to acquisition by UBS (1990-2004) McCaskill CSO & Packard have long-standing scientific and engineering collaboration on large scale EU research grants totaling ~€15M: McCaskill lead 3 on artificial and electronic chemical cells using smart microsystems (2004-2016) Packard & Zingg at Daptics developed AI design and discovery tools (2010-2020) McCaskill Roadmap Nanorobotic Surgery for University of Sydney as lead consultant (2018)
Chemelion Inc. formed (2020).
MICREAgents EU project, McCaskill lead: design and fabrication of programmable, electrochemically active chips:
– “smart chemical dust” (2012-2016)
– First 100µm sized electronic chiplets active in biofluids